Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Dillon SM, Lee EJ, Bramante JM, Barker E, Wilson CC.

J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):259-67. doi: 10.1097/01.qai.0000435603.50598.2b.

2.

Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.

Ahmad F, Tufa DM, Mishra N, Jacobs R, Schmidt RE.

AIDS Res Hum Retroviruses. 2015 Dec;31(12):1206-12. doi: 10.1089/aid.2015.0115. Epub 2015 Sep 9.

PMID:
26352913
3.

Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity.

Azzoni L, Papasavvas E, Chehimi J, Kostman JR, Mounzer K, Ondercin J, Perussia B, Montaner LJ.

J Immunol. 2002 Jun 1;168(11):5764-70.

4.

Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.

Naluyima P, Eller MA, Laeyendecker O, Quinn TC, Serwadda D, Sewankambo NK, Gray RH, Michael NL, Wabwire-Mangen F, Robb ML, Sandberg JK.

AIDS. 2014 Jun 1;28(9):1273-8. doi: 10.1097/QAD.0000000000000286.

5.

Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.

Lima JF, Oliveira LM, Pereira NZ, Mitsunari GE, Duarte AJ, Sato MN.

J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):463-71. doi: 10.1097/QAI.0000000000000350.

PMID:
25230289
6.

Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.

Goodier MR, Imami N, Moyle G, Gazzard B, Gotch F.

Clin Exp Immunol. 2003 Dec;134(3):470-6. Erratum in: Clin Exp Immunol. 2004 Feb;135(2):344.

7.

CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection.

Rutjens E, Mazza S, Biassoni R, Koopman G, Ugolotti E, Fogli M, Dubbes R, Costa P, Mingari MC, Greenwood EJ, Moretta L, De Maria A, Heeney JL.

Eur J Immunol. 2010 May;40(5):1440-50. doi: 10.1002/eji.200940062. Erratum in: Eur J Immunol. 2010 Jun;40(6):1819. DeMaria, Andrea [corrected to De Maria, Andrea].

8.

CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.

Milush JM, López-Vergès S, York VA, Deeks SG, Martin JN, Hecht FM, Lanier LL, Nixon DF.

Retrovirology. 2013 Dec 18;10:158. doi: 10.1186/1742-4690-10-158.

9.

Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals.

Montoya CJ, Velilla PA, Chougnet C, Landay AL, Rugeles MT.

Clin Immunol. 2006 Aug;120(2):138-46. Epub 2006 Apr 19.

PMID:
16624619
10.

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, O'Shea MA, Kinter A, Kovacs C, Moretta A, Fauci AS.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2886-91. Epub 2005 Feb 7.

11.

Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.

Jia M, Li D, He X, Zhao Y, Peng H, Ma P, Hong K, Liang H, Shao Y.

Clin Exp Immunol. 2013 Jan;171(1):107-16. doi: 10.1111/j.1365-2249.2012.04672.x.

12.

Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.

Conry SJ, Meng Q, Hardy G, Yonkers NL, Sugalski JM, Hirsch A, Davitkov P, Compan A, Falck-Ytter Y, Blanton RE, Rodriguez B, Harding CV, Anthony DD.

J Infect Dis. 2012 Apr 1;205(7):1131-41. doi: 10.1093/infdis/jis027. Epub 2012 Feb 20.

13.

Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.

Korbel DS, Norman PJ, Newman KC, Horowitz A, Gendzekhadze K, Parham P, Riley EM.

J Immunol. 2009 May 15;182(10):6426-34. doi: 10.4049/jimmunol.0804224.

14.

Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.

Conry SJ, Milkovich KA, Yonkers NL, Rodriguez B, Bernstein HB, Asaad R, Heinzel FP, Tary-Lehmann M, Lederman MM, Anthony DD.

J Virol. 2009 Nov;83(21):11175-87. doi: 10.1128/JVI.00753-09. Epub 2009 Aug 19.

15.

Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection.

Titanji K, Sammicheli S, De Milito A, Mantegani P, Fortis C, Berg L, Kärre K, Travi G, Tassandin C, Lopalco L, Rethi B, Tambussi G, Chiodi F.

Immunology. 2008 Feb;123(2):164-70. Epub 2007 Jul 11.

16.

IL-21 augments natural killer effector functions in chronically HIV-infected individuals.

Strbo N, de Armas L, Liu H, Kolber MA, Lichtenheld M, Pahwa S.

AIDS. 2008 Aug 20;22(13):1551-60. doi: 10.1097/QAD.0b013e3283089367.

17.

Changes in NK cell counts and receptor expressions and emergence of CD3(dim)/CD56+ cells in HIV-1 infected patients in China.

Fu GF, Hao S, Zhao JL, Xu XQ, Guo HX, Hu HY, Yang HT, Li L, Xu JS, Qiu T, Huan XP, Hou YY.

Viral Immunol. 2009 Apr;22(2):105-16. doi: 10.1089/vim.2008.0081.

PMID:
19326997
18.

Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.

Conroy MJ, Mac Nicholas R, Grealy R, Taylor M, Otegbayo JA, O'Dea S, Mulcahy F, Ryan T, Norris S, Doherty DG.

J Viral Hepat. 2015 Mar;22(3):335-45. doi: 10.1111/jvh.12299. Epub 2014 Sep 3.

PMID:
25186004
19.

Differential production of IFN-gamma, analyzed at the single-cell level, by specific subsets of human NK and T cells from healthy and HIV(+) subjects.

Vitale M, Caruso A, Licenziati S, Rodella L, Fiorentini S, Zauli G, Castelli F, Manzoli FA, Turano A.

Cytometry. 2000 Mar 1;39(3):189-94.

PMID:
10685075
20.

Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.

Hu PF, Hultin LE, Hultin P, Hausner MA, Hirji K, Jewett A, Bonavida B, Detels R, Giorgi JV.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Nov 1;10(3):331-40.

PMID:
7552495

Supplemental Content

Support Center